Skip to main content

HomeResearchCGRP

CategoryRecovery
SafetyMedium Risk
StatusResearch Only

CGRP

Calcitonin Gene-Related Peptide · alpha-CGRP · beta-CGRP

CategoryRecovery
Half-life
Routesubcutaneous, intravenous
RiskMedium Risk
Providers2 listed

About CGRP

Binds CLR/RAMP1 receptor complex. Causes vasodilation via cAMP/PKA/nitric oxide pathway. Modulates nociceptive signaling in the trigeminal system. Promotes bone healing and has anti-inflammatory effects in peripheral tissues.

A 37-amino acid neuropeptide released from sensory nerve fibers and one of the most potent endogenous vasodilators. Central to migraine pathophysiology and studied for pain modulation, wound healing, and bone repair.

Research Areas

vasodilationpain modulationwound healingbone repair

Regulatory & Evidence

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Review contraindications and administration guidelines before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Medium Risk

Moderate risk profile. Review all reported considerations carefully before use.

Reported contraindications & considerations

Cardiovascular ConditionPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find CGRP

2 providers

Frequently Asked Questions — CGRP

A 37-amino acid neuropeptide released from sensory nerve fibers and one of the most potent endogenous vasodilators. Central to migraine pathophysiology and studied for pain modulation, wound healing, and bone repair.

vasodilation, pain modulation, wound healing, bone repair.

2 providers in the directory currently offer CGRP.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.